These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 13561287)

  • 1. [Future plans for investigation and production of drugs].
    SMAHEL O
    Cas Lek Cesk; 1958 Jun; 97(23-24):728-9. PubMed ID: 13561287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
    Wright C; Schnoll S; Bernstein D
    Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reform plans for pharmaceutical legislation: permit for drugs & drug patents].
    MARTELLIERE E
    Prod Pharm; 1959 Apr; 14(4):213-9 concl. PubMed ID: 13645809
    [No Abstract]   [Full Text] [Related]  

  • 5. Examining the production costs of antiretroviral drugs.
    Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
    AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alice Huxley and Nick Miles of Speedel on the company's pipeline and future plans. Interview by Christopher Watson and Stephen Carney.
    Huxley A; Miles N
    Drug Discov Today; 2005 Jul; 10(13):881-3. PubMed ID: 15993805
    [No Abstract]   [Full Text] [Related]  

  • 7. The Minor Use and Minor Species Animal Health Act: past, present, and future.
    Haley CJ
    Food Drug Law J; 2006; 61(1):13-43. PubMed ID: 16838456
    [No Abstract]   [Full Text] [Related]  

  • 8. [Future challenges and prospects for drug companies].
    Lajoux C
    Bull Acad Natl Med; 2008 Apr; 192(4):623-30; discussion 630-2. PubMed ID: 19024935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development plans for new drug abandoned.
    AIDS Patient Care STDS; 2003 Oct; 17(10):540. PubMed ID: 14608974
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the production of drugs in Czechoslovakia].
    Palkoska J
    Cesk Farm; 1965 Aug; 14(6):254-9. PubMed ID: 5852313
    [No Abstract]   [Full Text] [Related]  

  • 11. [The growth of the production of drugs from 1966 to 1970].
    Labzin VP
    Med Prom SSSR; 1966 Jun; 20(6):3-6. PubMed ID: 6000221
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contemporary problems of pharmaceutical research, production & utilization of drugs].
    SMAHEL O
    Cesk Zdrav; 1958 Aug; 6(8):423-9. PubMed ID: 13585492
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of the pharmaceutical industry].
    Aumonier J
    Ann Pharm Fr; 2003 Nov; 61(6):378-82. PubMed ID: 14639188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orphan drugs of the future?
    Service RF
    Science; 2004 Mar; 303(5665):1798. PubMed ID: 15031491
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug production, trafficking and trade in Asia and Pacific Island countries.
    Reid G; Devaney ML; Baldwin S
    Drug Alcohol Rev; 2006 Nov; 25(6):647-50. PubMed ID: 17132580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study to build a database on seven anti-hypertensive drugs.
    Fujita T; Miura Y; Mayama T
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):41-6. PubMed ID: 15534857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical price differences in the EU: investigation from cardiovascular disease drugs.
    Timur A; Picone G
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):251-6. PubMed ID: 19527097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outlook for peptide drugs and the intricate relationship between the Active Pharmaceutical Ingredients manufacturer and their sponsors.
    de Chastonay J
    J Pept Sci; 2005 Nov; 11(11):754-5. PubMed ID: 16215959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary analysis of ginseng industry in Wisconsin].
    Hu L; Zhang WS
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(14):1649-53. PubMed ID: 18841757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rise of the generic drug market and its implications for dermatology.
    Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
    J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.